Publish Date May 11, 2026 Sustainable and Scalable Strategies for Safe and Effective Administration of Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma in Outpatient and Community Settings Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Print Share by Email CME | QPP IA (MIPS) | 4.50 Credits
